#MSKCART17 Conference Hashtag

Clinical Application of CAR T Cells

Chimeric antigen receptor (CAR) T-cell (’Living Drug’) immunotherapy is showing promising results in the treatment of cancers. Over the years, MSK has accumulated a breadth of knowledge about developing and translating these clinical trials from bench to bedside. MSK faculty, along with national and international experts, will discuss the clinical and translational aspects of cell therapies.
Conference Website

#MSKCART17 is a conference hashtag submitted by @DrMiguelPerales